Particle size and composition related to adverse health effects in aged, sensitive rats.
Small increases in concentrations of ambient particulate matter (PM*) have been linked to adverse health effects, especially in older people and people with preexisting respiratory disease. Some epidemiologic studies have shown the association to be stronger with PM less than 2.5 microm in aerodynamic diameter (PM2.5) than with PM less than 10 microm in aerodynamic diameter (PM10). Some scientists and regulators suggest that 2.5 microm might be an arbitrary cutoff and that the effects might be more pronounced for PM less than 0.1 microm in aerodynamic diameter (ultrafine PM). Our first aim was to determine the relation between size of respirable particles and particle toxicity, as well as the health effects of short-term increases (spikes) in particle concentration against backgrounds of relatively low or high baseline exposures. Our second aim was to determine the effect of spikes in concentration of fine particles (0.7 microm in mass median aerodynamic diameter [MMAD]) and ultrafine particles (35 nm in count median diameter [CMD]) of disparate composition: vanadium pentoxide (V2O5) and carbon black. The relative toxicity of these particles was determined in aged rats with mild pulmonary inflammation induced by instilled endotoxin. Our third aim was to determine the influence of age (aged vs young adult) on particle-induced toxicity in these rats.
Hahn
Fletcher F
FF
Experimental Toxicology Program, Lovelace Respiratory Research Institute, 2425 Ridgecrest Dr SE, Albuquerque NM 87108, USA. FHahn.lrri.org
Barr
Edward B
EB
Ménache
Margaret G
MG
Seagrave
JeanClare
J
D000367:Age Factors; D000818:Animals; D002244:Carbon / Q000008:administration & dosage / Q000009:adverse effects*; D019570:Inhalation Exposure / Q000032:analysis*; D008297:Male; D009516:New Mexico; D010316:Particle Size; D011014:Pneumonia / Q000503:physiopathology; D051381:Rats; D011916:Rats, Inbred F344; D017207:Rats, Sprague-Dawley; D017968:Vanadium Compounds / Q000008:administration & dosage / Q000009:adverse effects*
D017968:Vanadium Compounds; D002244:Carbon; C066075:vanadium pentoxide